Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
US Army
Cipla
Harvard Business School
Citi
Federal Trade Commission
Teva
Colorcon
QuintilesIMS
McKinsey

Generated: February 21, 2018

DrugPatentWatch Database Preview

Cefaclor - Generic Drug Details

« Back to Dashboard

What are the generic sources for cefaclor and what is the scope of cefaclor freedom to operate?

Cefaclor
is the generic ingredient in four branded drugs marketed by Lilly, Ceph Intl, Dava Pharms Inc, Hikma, Ivax Sub Teva Pharms, Ranbaxy, Teva, Watson Labs Inc, Yung Shin Pharm, Facta Farma, Ranbaxy Labs Ltd, and World Gen, and is included in thirty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for cefaclor. Eleven suppliers are listed for this compound.
Pharmacology for cefaclor
Medical Subject Heading (MeSH) Categories for cefaclor

US Patents and Regulatory Information for cefaclor

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc CEFACLOR cefaclor FOR SUSPENSION;ORAL 064206-001 Feb 18, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Yung Shin Pharm CEFACLOR cefaclor FOR SUSPENSION;ORAL 065412-002 Feb 17, 2012 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Inc CEFACLOR cefaclor FOR SUSPENSION;ORAL 064204-001 Feb 18, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Inc CEFACLOR cefaclor CAPSULE;ORAL 064148-002 May 23, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms CEFACLOR cefaclor FOR SUSPENSION;ORAL 064085-001 Apr 28, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Facta Farma CEFACLOR cefaclor FOR SUSPENSION;ORAL 062206-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly CECLOR CD cefaclor TABLET, EXTENDED RELEASE;ORAL 050673-002 Jun 28, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Inc CEFACLOR cefaclor FOR SUSPENSION;ORAL 064205-001 Feb 18, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ranbaxy CEFACLOR cefaclor FOR SUSPENSION;ORAL 064164-001 Oct 2, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ceph Intl CEFACLOR cefaclor CAPSULE;ORAL 062205-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Queensland Health
Merck
Mallinckrodt
QuintilesIMS
AstraZeneca
Cipla
Cantor Fitzgerald
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot